Multiple scoring systems have been developed to assess biochemical response to UDCA treatment [92]
Scoring System | Criteria for treatment of non-responsiveness | Time of evaluation from treatment initiation |
---|---|---|
Barcelona | ALP decrease ≤ 40% of the initial level and ALP ≥ ULN | 12 months |
Paris II | ALP ≥ 1.5 × ULN or total bilirubin > 1 mg/dL or AST ≥ 1.5 × ULN | 12 months |
Rotterdam | Total bilirubin ≥ ULN, albumin < LLN, or both | 12 months |
Toronto | ALP ≥ 1.67 × ULN | 24 months |
UK-PBC formula | Uses baseline albumin and platelet count, along with 12-month measurements of total bilirubin, ALP, and AST or ALT | 12 months |
GLOBE formula | Uses age, total bilirubin, ALP, albumin, and platelet count | 12 months |
MBAE, IE, and AAAA: Investigation, Writing—original draft. JLB: Writing—review & editing.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2024.